Skip to main content
永顺生物 logo

永顺生物 — Investor Relations & Filings

Ticker · 920729 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2023-12-28 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920729

About 永顺生物

https://www.winsun-gd.com/

Guangdong Winsun Bio-Pharmaceutical Co., Ltd. is a specialized enterprise focused on the research, development, production, and distribution of veterinary biological products. The company primarily develops vaccines for livestock and poultry, with a significant emphasis on swine and avian health. Its product portfolio includes live and inactivated vaccines targeting major diseases such as classical swine fever, porcine reproductive and respiratory syndrome (PRRS), and avian influenza. Winsun Bio-Pharmaceutical leverages advanced biotechnology to provide comprehensive animal disease prevention and control solutions. The company maintains a strong focus on technological innovation and quality management, operating multiple GMP-certified production lines to ensure the efficacy and safety of its biological preparations. Its research initiatives often involve collaborations with academic institutions to advance veterinary medicine and support the animal husbandry sector.

Recent filings

Filing Released Lang Actions
2023 年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2023 second extraordinary shareholders' meeting of Guangdong Yongshun Biopharmaceutical Co., Ltd. It includes information about the meeting's convening, attendance, agenda items, voting results on various proposals including board and supervisory board elections, amendments to company bylaws, and governance rules. It also contains legal opinions confirming the legality of the meeting and the validity of the voting process. The document is not a financial report, earnings release, or presentation, but rather an official record of shareholder voting outcomes and board/management changes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (7932 characters) and content confirm it is the actual voting results announcement, not just a notice or report publication announcement.
2023-12-28 Chinese
第五届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the first meeting of the fifth board of directors of Guangdong Yongshun Biopharmaceutical Co., Ltd. It details the election of board chairman, vice chairman, appointment of senior management, and establishment of board committees. The document includes voting results and references to related announcements on the stock exchange platform. It does not contain financial statements or detailed financial analysis, nor is it a transcript or presentation. It is clearly an announcement of board/management changes and decisions. Therefore, it fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is a direct announcement, not a report publication notice or certification letter.
2023-12-28 Chinese
董事长、副董事长、监事会主席、 高级管理人员、职工代表监事换届公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election and appointment of the company's chairman, vice chairman, supervisory board chairman, senior management, and employee representative supervisors. It details the changes in the board and senior management personnel, including their qualifications and terms of office. There is no financial data, earnings information, or report publication mentioned. The content focuses on management and board changes, which fits the category of Board/Management Information (MANG). The document length is 2598 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2023-12-28 Chinese
第五届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution from the first meeting of the fifth supervisory board of Guangdong Yongshun Biopharmaceutical Co., Ltd. It details the meeting date, attendance, agenda, and voting results for the election of the supervisory board chairman. It references another announcement for detailed personnel changes but itself focuses on board/management meeting resolutions. There is no financial data, audit information, or report publication mentioned. The content fits the category of Board/Management Information (MANG) as it concerns changes and resolutions related to the company's supervisory board.
2023-12-28 Chinese
2023 年第二次职工代表大会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolution passed at the company's 2023 second employee representative meeting. It details the meeting date, attendance, agenda, and voting results related to the election of an employee representative supervisor to the supervisory board. It does not contain financial statements, audit information, or detailed management discussion. It is not an annual or interim report, earnings release, or investor presentation. It is also not a proxy solicitation or voting results announcement for shareholders but rather a resolution announcement from an internal employee representative meeting. The document is short (1031 characters) and serves as an official announcement of meeting resolutions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous official announcements that do not fit other specific categories.
2023-12-28 Chinese
第四届监事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the supervisory board (监事会) of Guangdong Yongshun Biopharmaceutical Co., Ltd. It details the meeting date, attendance, and voting results on various proposals including the election of new supervisory board members, use of company funds for financial products, anticipated related-party transactions, and amendments to the company charter. The document does not contain financial statements or detailed financial data but rather reports on board meeting decisions and governance matters. It also references other announcements published on the stock exchange platform for detailed information. The document length is 2687 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. This fits best under Board/Management Information (MANG) as it concerns supervisory board meeting resolutions and management decisions.
2023-12-12 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.